Stanford Hospital & Clinics Begins New Neurogenetics Oncology Program

Stanford Hospital & Clinics in Palo Alto, Calif., announced the opening of its new clinical neurogenetics oncology program.

The program is designed to treat complex tumor-multiplying diseases, such as neurofibromatosis 2, schwannomatosis tuberous sclerosis, von Hippel-Lindau disease, Sturge Weber syndrome and hemorrhagic telangiectasia. These disorders are rare and often have no cure.

The program includes a multidisciplinary team that provides ongoing surveillance and coordination of all treatments and check-ups.

More Articles on Hospital Oncology:

Commonwealth Cancer Centers of Kentucky Joins UK Markey Cancer Center Network
Pacific Cancer Institute of Maui to Begin $7M Expansion

Mayo Clinic Names Coborn Cancer Center First Member of New Cancer Care Network

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars